63
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Four-day pulse of sodium cromoglycate modulates pulmonary vessel wall remodeling during 21-day hypoxia in rats

, & ORCID Icon
Pages 1-12 | Received 27 Mar 2017, Accepted 14 Oct 2017, Published online: 11 Jan 2018

References

  • Novotný T, Krejčí J, Malíková J, et al. Mast cell stabilization with sodium cromoglycate modulates pulmonary vessel wall remodeling during four-day hypoxia in rats. Exp Lung Res. 2015;41(5):283–292. doi:10.3109/01902148.2015.1018558.
  • Lachmanová V, Hniličková O, Povýšilová, Hampl V, Herget J. N-acetylcysteine inhibits hypoxic pulmonary hypertension most effectively in the initial phase of chronic hypoxia. Life Sci. 2005;77(2):175–182. doi:10.1016/j.lfs.2004.11.027.
  • Baňasová A, Maxová H, Hampl V, et al. Prevention of mast cell degranulation by disodium cromoglycate attenuates the development of hypoxic pulmonary hypertension in rats exposed to chronic hypoxia. Respiration. 2008;76(1):102–107. doi:10.1159/000121410.
  • Mina Y, Rinkevich-Shop S, Konen E, et al. Landa-Rouben N: Mast cell inhibition attenuates myocardial damage, adverse remodeling and dysfunction during fulminant myocarditis in rat. J Cardiovasc Pharmacol Ther. 2013;18(2):152–161. doi:10.1177/1074248412458975.
  • Hemmati AA, Nazari Z, Motlagh ME, Goldasteh S. The role of sodium cromolyn in treatment of paraquat-induced pulmonary fibrosis in rat. Pharmacol Res. 2002;46(3):229–234. doi:10.1016/S1043-6618(02)00122-6.
  • Krystel-Whittemore M, Dileepan KN, Wood JG. Mast cell: A multi-functional master cell. Front Immunol. 2016;6:620. doi:10.3389/fimmu.2015.00620.
  • Herget J, Suggett AJ, Leach E, Barer GR. Resolution of pulmonary hypertension and other features induced by chronic hypoxia in rats during complete and intermittent normoxia. Thorax. 1978;33(4):468–473. doi:10.1136/thx.33.4.468.
  • Wilhelm J, Vaňková M, Maxová H, Šišková A. Hydrogen peroxide production by alveolar macrophages is increased and its concentration is elevated in the breath of rats exposed to hypoxia: relationship to lung lipid peroxidation. Physiol Res. 2003;52(3):327–332.
  • Maxová H, Hezinová A, Vízek M. Disodium cromoglycate attenuates hypoxia induced enlargement of end-expiratory lung volume in rats. Physiol Res. 2011;60(5):831–834.
  • Herget J, Novotná J, Bíbová J, Povýšilová V, Vaňková M, Hampl V. Metalloproteinase inhibition by Batimastat attenuates pulmonary hypertension in chronically hypoxic rats. Am J Physiol Lung Cell Mol Physiol. 2003;285(1):L199–L208. doi:10.1152/ajplung.00167.2002.
  • Novotná J, Herget J. Possible role of matrix metalloproteinases in reconstruction of peripheral pulmonary arteries induced by hypoxia. Physiol Res. 2002;51(4):323–334.
  • Leach E, Howard P, Barer GR. Resolution of hypoxic changes in the heart and pulmonary arterioles of rats during intermittent correction of hypoxia. Clin Sci Mol Med. 1977;52(2):153–162.
  • Vajner L, Vytášek R, Lachmanová V, et al. Acute and chronic hypoxia as well as 7-day recovery from chronic hypoxia affects the distribution of pulmonary mast cells and their MMP-13 expression in rats. Int J Exp Pathol. 2006;87(5):383–391. doi:10.1111/j.1365-2613.2006.00493.x.
  • Gardi C, Calzoni P, Marcolongo P, Cavarra E, Vanni L, Lungarella G. Collagen breakdown products and lung collagen metabolism: an in vitro study on fibroblast cultures. Thorax. 1994;49(4):312–328. doi:10.1136/thx.49.4.312.
  • Theoharides TC, Wang L, Pang X, et al. Cloning and cellular localization of the rat mast cell 78-kDa protein phosphorylated in response to the mast cell “stabilizer” cromolyn. J Pharmacol Exp Ther. 2000;294(3):810–821.
  • Bartelds B, van Loon RLE, Mohaupt S, et al. Mast cell inhibition improves pulmonary vascular remodeling in pulmonary hypertension. Chest. 2012;141(3):651–660. doi:10.1378/chest.11-0663.
  • Hoffmann J, Yin J, Kukucka M, et al. Mast cells promote lung vascular remodelling in pulmonary hypertension. Eur Respir J. 2011;37:1400–1410. doi:10.1183/09031936.00043310.
  • Dahal BK, Heuchel R, Pullamsetti SS, et al. Hypoxic pulmonary hypertension in mice with constitutively active platelet-derived growth factor receptor-β. Pulm Circ. 2011;1(2):259–268. doi:10.4103/2045-8932.83448.
  • Voelkel NF, Tuder RM. Hypoxia-induced pulmonary vascular remodeling: a model for what human disease? J Clin Invest. 2000;106(6):733–738. doi: 10.1172/JCI11144.
  • Feltis BN, Wignarajah D, Reid DW, Ward C, Harding R, Walters EH. Effects of inhaled fluticasone on angiogenesis and vascular endothelial growth factor in asthma. Thorax. 2007;62(4):314–319. doi:10.1136/thx.2006.069229.
  • Ball MK, Waypa GB, Mungai PT, et al. Regulation of hypoxia-induced pulmonary hypertension by vascular smooth muscle hypoxia-inducible factor-1α. Am J Respir Crit Care Med. 2014;189(3):314–324. doi:10.1164/rccm.201302-0302OC.
  • Rose F, Grimminger F, Appel J, et al. Hypoxic pulmonary artery fibroblasts trigger proliferation of vascular smooth muscle cells: role of hypoxia-inducible transcription factors. FASEB J. 2002;16(12):1660–1661.
  • Tabima DM, Chesler NC. The effects of vasoactivity and hypoxic pulmonary hypertension on extralobar pulmonary artery biomechanics. J Biomech. 2010;43(10):1864–1869. doi:10.1016/j.jbiomech.2010.03.033.
  • Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat M-L, Gabbiani G. The myofibroblast. One function, multiple origins. Am J Pathol. 2007;170(6):1807–1816. doi:10.2353/ajpath.2007.070112.
  • Paddenberg R, Stieger P, von Lilien AL, et al. Rapamycin attenuates hypoxia-induced pulmonary vascular remodeling and right ventricular hypertrophy in mice. Respir Res. 2007;8:15. doi:10.1186/1465-9921-8-15.
  • Meyrick B, Reid L. Hypoxia-induced structural changes in the media and adventitia of the rat hilar pulmonary artery and their regression. Am J Pathol. 1980;100(1):151–178.
  • Semenza GL. Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol Med. 2001;7(8):345–350. doi:10.1016/S1471-4914(01)02090-1.
  • Semenza GL. O2-regulated gene expression: transcriptional control of cardiorespiratory physiology by HIF-1. J Appl Physiol. (1985) 2004;96(3):1173–1177. doi:10.1152/japplphysiol.00770.2003.
  • Pietra GG, Capron F, Stewart S, et al. Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol. 2004;43(12 Suppl):25S–32S. doi:10.1016/j.jacc.2004.02.033.
  • Witter K, Tonar Z, Schöpper H. How many layers has the adventitia? – Structure of the arterial tunica externa revisited. Anat Histol Embryol. 2017;46(2):110–120. doi: 10.1111/ahe.12239.
  • Neale MG, Brown K, Hodder RW, Auty RM. The pharmacokinetics of sodium cromoglycate in man after intravenous and inhalation administration. Br J Clin Pharmacol. 1986;22(4):373–382. doi:10.1111/j.1365-2125.1986.tb02905.x.
  • Wernersson S, Pejler G. Mast cell secretory granules: armed for battle. Nat Rev Immunol. 2014;14(7):478–494. doi:10.1038/nri3690.
  • Xu X, Guan S, He B, Wang J. Active role of the predecidual-like zone in endometrial shedding in a mouse menstrual-like model. Eur J Histochem. 2013;57(3):e25. doi: 10.4081/ejh.2013.e25.
  • Howell K, Preston RJ, McLoughlin P. Chronic hypoxia causes angiogenesis in addition to remodelling in the adult rat pulmonary circulation. J Physiol. 2003;547(Pt 1):133–145. doi:10.1113/jphysiol.2002.030676.
  • Cruse G, Bradding P. Mast cells in airway diseases and interstitial lung disease. Eur J Pharmacol. 2016;778:125–138. doi:10.1016/j.ejphar.2015.04.046.
  • Finn DF, Walsh JJ. Twenty-first century mast cell stabilizers. Br J Pharmacol. 2013;170(1):23–37. doi:10.1111/bph.12138.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.